logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
For ProvidersRequest DemoJoin Research Panel
For BusinessHCP ChannelCommercial O/SEngageMarketplaceOneHubInsight
Tools & MorePrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyAboutInsightsCareersContactSecurity
Legit Script Certified
Get the latest insights in your inbox
Follow us
Legit Script Certified
  • Terms and Conditions
  • Privacy Policy
  • © 2025 PrescriberPoint. All Rights Reserved.

    • Medications for Influenza A Virus

    FiltersReset Filters
    8 results

    • amantadine hydrochloride

      (Amantadine Hydrochloride)
      Advagen Pharma Limited
      Usage: Amantadine hydrochloride capsules are indicated for the prophylaxis and treatment of influenza A virus infections, as well as for the treatment of Parkinson's disease and drug-induced extrapyramidal reactions. It is not a substitute for vaccination and is less effective than levodopa for Parkinson's disease.

    • oseltamivir

      (OSELTAMIVIR)
      Alembic Pharmaceuticals Inc.
      Usage: Oseltamivir phosphate is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset. It is also used for prophylaxis in individuals 1 year and older. Vaccination is recommended annually and resistance may impact effectiveness.

    • oseltamivir phosphate

      (Oseltamivir Phosphate)
      Neolpharma Inc
      Usage: Oseltamivir phosphate is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours. It is also used for prophylaxis of influenza in individuals 1 year and older.

    • oseltamivir phosphate

      (Oseltamivir phosphate)
      Novadoz Pharmaceuticals LLC
      Usage: Oseltamivir phosphate capsules are indicated for the treatment of influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours, and for prophylaxis in patients 1 year and older. It is not a substitute for annual influenza vaccination.

    • oseltamivir phosphate

      (Oseltamivir Phosphate)
      Lupin Pharmaceuticals Inc
      Usage: Oseltamivir phosphate for oral suspension is indicated for treating acute influenza A and B in patients aged 2 weeks and older within 48 hours of symptom onset, and for prophylaxis in individuals 1 year and older. It is not a substitute for annual vaccination and has specific use limitations.

    • oseltamivir phosphate

      (oseltamivir phosphate)
      Novadoz Pharmaceuticals LLC
      Usage: Oseltamivir phosphate for oral suspension is indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older with symptoms for no more than 48 hours, and for prophylaxis in patients aged 1 year and older. It is not a substitute for vaccination.

    • oseltamivir phosphate

      (OSELTAMIVIR PHOSPHATE)
      Aurobindo Pharma Limited
      Usage: Oseltamivir phosphate oral suspension is indicated for treating acute, uncomplicated influenza A and B in patients aged 2 weeks and older within 48 hours of symptoms onset, and for prophylaxis in patients 1 year and older. It is not a substitute for vaccination and may have limitations due to resistance.

    • oseltamivir phosphate

      (Oseltamivir)
      AvKARE
      Usage: Oseltamivir phosphate capsules are indicated for the treatment of acute, uncomplicated influenza A and B in patients aged 2 weeks and older, symptomatic for no more than 48 hours, and for prophylaxis in patients aged 1 year and older. It is not a substitute for vaccination.